Home Biosimilar Antibodies Others Others Codrituzumab (Anti-GPC3 / Glypican-3)
For research use only. Not for use in humans.

Codrituzumab (Anti-GPC3 / Glypican-3)

Synonyms: GC33; RO5137382

Codrituzumab is a monoclonal antibody targeting GPC3 (glypican-3) which is an oncofetal protein expressed on the cell surface of hepatocellular carcinoma (HCC). Codrituzumab induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth. MW: 150 KD.

Codrituzumab (Anti-GPC3 / Glypican-3)

Quality Control

Batch: A247601 Purity: 99% Protein concentration: 5.63mg/ml Endotoxin Level: ＜1EU/mg
99

Mechanism of Action

Description
Codrituzumab is a monoclonal antibody targeting GPC3 (glypican-3) which is an oncofetal protein expressed on the cell surface of hepatocellular carcinoma (HCC). Codrituzumab induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth. MW: 150 KD.

Product Details

CAS No. 1365267-33-9
Molecular Weight 150 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.